Patent details

EP3458053 Title: USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS

Basic Information

Publication number:
EP3458053
PCT Application Number:
US2017033688
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP178003109
PCT Publication Number:
WO2017201501
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
French Title of Invention:
UTILISATION DU RILUZOLE, DE PROMÉDICAMENTS DU RILUZOLE OU D'ANALOGUES DU RILUZOLE AVEC DES IMMUNOTHÉRAPIES POUR TRAITER LES CANCERS
German Title of Invention:
VERWENDUNG VON RILUZOL, RILUZOLPRODRUGS ODER RILUZOLANALOGA MIT IMMUNTHERAPIEN ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
19/05/2017
Grant date:
08/12/2021
EP Publication Date:
27/03/2019
PCT Publication Date:
23/11/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/12/2021
EP B1 Publication Date:
08/12/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/05/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/01/2022
 
 

Name:
Biohaven Therapeutics Ltd.
Address:
215 Church Street, New Haven, CT 06510, United States (US)

History of Owners

From:
01/12/2021
To:
21/01/2022

Name:
Biohaven Pharmaceutical Holding Company Ltd.
Address:
234 Church Street Suite 301, New Haven, CT 06520, United States (US)

Agent

1

Name:
MARKS & CLERK LLP
From:
12/08/2022
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

2

Name:
MARKS & CLERK LLP
From:
04/02/2022
Address:
B.P. 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:
12/08/2022

Inventor

Name:
CORIC, Vladimir
Address:
United States (US)

Priority

Priority Number:
201662339433 P
Priority Date:
20/05/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/428; C07D 277/82; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202149
Publication date:
08/12/2021
Description:
Grant (B1)

2

Issue number:
202150
Publication date:
15/12/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202208
Publication date:
23/02/2022
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/05/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
07/02/2022 Outgoing Correspondence 1
04/02/2022 Power Of Attorney 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56